# Remimazolam-Flumazenil Versus Sevoflurane for Hysteroscopic Day Surgery

> **NCT07663877** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Chung-Ang University Gwangmyeong Hospital** · enrollment: 124 (estimated)

## Conditions studied

- Hysteroscopy
- Ambulatory Surgery
- General Anesthesia

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Flumazenil
- **DRUG:** Sevoflurane
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT07663877
- **Lead sponsor:** Chung-Ang University Gwangmyeong Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663877, "Remimazolam-Flumazenil Versus Sevoflurane for Hysteroscopic Day Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*